Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Nasdaq in Correction: ETF Strategies to Play

Published 01/20/2022, 01:00 AM
Updated 07/09/2023, 06:31 AM

The Nasdaq, heavy on technology and growth stocks, is now off 10% from its November record, ensuring the fact that it has entered a correction territory. The Nasdaq Composite has lost 8% this year as investors continue to walk out of the high-growth tech shares as interest rates surge to start the new year.

There are heightened rising rate worries as the Fed is expected to hike rates in March to contain a sky-high inflation. Investors are wagering on 89.9% chances of a 25-bp interest rate hike in March, according to CME Group's (NASDAQ:CME) FedWatch Tool, and a 48.4% chance that rates will rise again by 25 bps in May and 43.9% probability that the rates will hover around 75-100 bps after the Fed’s June meeting. About 45.1% believe that 75-100 bps of rates will be seen after the meeting in July. If this happens, there will be three Fed rate hikes in the coming six months (read: Bet on Inverse Treasury ETFs Now to Play Rise in Yields).

President Joe Biden also said he favors Federal Reserve Chairman Jerome Powell’s expected move to start tightening monetary policy. Benchmark U.S. treasury yield jumped to 1.87% on Jan 18, 2022 (this year’s high so far) from 1.63% from the start of the month. No wonder, high-growth stocks will take a beating. Growth stocks’ valuations swelled during the pandemic thanks to ultra-easy monetary policies.

Since the growth sector relies on easy borrowing for superior growth and its value depends heavily on future earnings, a rise in long-term yields cuts the present value of companies’ future earnings. Apart from the rate issues, the economic reopening amid vaccination and the easing Omicron concerns have been leading investors away from stay-at-home tech stocks.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Against this backdrop, below we highlight a few ETF strategies that could be intriguing right now.

Short Nasdaq

Given the sluggish backdrop, bearish investors may want to go near-term short on the Nasdaq- 100 Index. ProShares UltraPro Short QQQ SQQQ, ProShares Short QQQ (PSQ) and ProShares UltraShort QQQ (QID) are some of options to play around.

While the strategy is highly beneficial for short-term traders, it could lead to huge losses compared with traditional funds in fluctuating markets. Further, their performance could vary significantly from the actual performance of the underlying index over the longer period compared to a shorter period (such as, weeks or months).

Play Value ETFs

Value stocks have fared way better than growth and momentum stocks this year. SPDR Portfolio S&P 500 Value ETF SPYV has lost 0.9% versus the 7.3% decline in SPDR Portfolio S&P 500 Growth ETF SPYG and 8.8% decline in iShares MSCI USA Momentum Factor ETF (MTUM). Value stocks perform better in a low-rate environment. The favorable operating backdrop and damn cheap valuation are leading value stocks higher.

Consumer Staples ETFs: A Better Bet?

U.S. consumers are feeling the heat of continuously rising inflation levels. The latest disappointing preliminary consumer sentiment readings for early January that have slipped to the second-lowest level in a decade speaks of the same. The University of Michigan’s preliminary consumer sentiment declined to 68.8 in early January from 70.6 last month.

The metric lagged the market forecast of a fall to 70.0, per the Reuters survey on economists. It means that consumer discretionary stocks may be out of favor for some time now and consumer staples stocks should continue to win as these are essentials and non-cyclical in nature. Vanguard Consumer Staples ETF VDC thus looks to be a great bet. It yields 2.17% annually – which is benchmark-beating too (read: Here's Why You Should Invest in Consumer Staples ETFs).

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Healthcare: Is What Just Doctor Ordered?

As long as COVID-19 fear is around, demand for therapies and vaccines will remain strong. Hence, one should keep a close watch on Health Care Select Sector SPDR ETF (NYSE:XLV) XLV. The sector’s lure is timeless. No matter whether there is inflation or rising rates, people need to buy their medicine and visit hospitals should the need be. XLV has a Zacks Rank #1 (Strong Buy).

Time for High-Dividend ETFs?

Dividend is among the investing themes that should be under radar amid the ongoing volatility. Even if the stock or the fund falls, higher current income would go a long way in protecting investors’ total returns. High-dividend ETFs provide investors avenues to make up for capital losses, if that happens at all. ALPS Sector Dividend Dogs ETF SDOG, which is designed to measure of the performance of U.S. large-cap equities with above-average dividend yields is a good bet right now. It yields 3.48% annually. SDOG is up 3.5% this year.


Infrastructure Stock Boom to Sweep America

A massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It’s bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made.

The only question is “Will you get into the right stocks early when their growth potential is greatest?”

Zacks has released a Special Report to help you do just that, and today it’s free. Discover 7 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
Download FREE: How to Profit from Trillions on Spending for Infrastructure >>

Click to get this free report

Health Care Select Sector SPDR ETF (XLV): ETF Research Reports

Vanguard Consumer Staples ETF (VDC): ETF Research Reports

ALPS Sector Dividend Dogs ETF (SDOG): ETF Research Reports

ProShares UltraPro Short QQQ (SQQQ): ETF Research Reports

SPDR Portfolio S&P 500 Growth ETF (SPYG): ETF Research Reports

SPDR Portfolio S&P 500 Value ETF (SPYV): ETF Research Reports

To read this article on Zacks.com click here.

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.